(Q46355702)

21 December 2017

title

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome (English)

1 reference

21 December 2017

1 reference

3

1 reference

21 December 2017

Sabine Strehl

14

1 reference

21 December 2017

Jean-Pierre Bourquin

Jean-Pierre Bourquin

26

0 references

Giuseppe Basso

Giuseppe Basso

10

0 references

Anthony R Green

Anthony R Green

28

0 references

Martin Schrappe

12

Martin Schrappe

1 reference

21 December 2017

13

Martin Stanulla

1 reference

21 December 2017

Arndt Borkhardt

18

Arndt Borkhardt

1 reference

21 December 2017

Jan Trka

20

Jan Trka

1 reference

21 December 2017

author name string

Dani Bercovich

1

1 reference

21 December 2017

Ithamar Ganmore

2

1 reference

21 December 2017

Gilad Wainreb

4

1 reference

21 December 2017

Yehudit Birger

5

1 reference

21 December 2017

Arava Elimelech

6

1 reference

21 December 2017

Chen Shochat

7

1 reference

21 December 2017

Giovanni Cazzaniga

8

1 reference

21 December 2017

Andrea Biondi

9

1 reference

21 December 2017

Gunnar Cario

11

1 reference

21 December 2017

Oskar A Haas

15

1 reference

21 December 2017

Georg Mann

16

1 reference

21 December 2017

Vera Binder

17

1 reference

21 December 2017

Helena Kempski

19

1 reference

21 December 2017

Bella Bielorei

21

1 reference

21 December 2017

Smadar Avigad

22

1 reference

21 December 2017

Batia Stark

23

1 reference

21 December 2017

Owen Smith

24

1 reference

21 December 2017

Nicole Dastugue

25

1 reference

21 December 2017

Nir Ben Tal

27

1 reference

21 December 2017

Shai Izraeli

29

1 reference

21 December 2017

language of work or name

English

0 references

publication date

19 September 2008

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

372

1 reference

21 December 2017

page(s)

1484-1492

1 reference

21 December 2017

issue

9648

1 reference

21 December 2017

Pattern of malignant disorders in individuals with Down's syndrome.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Childhood acute lymphoblastic leukaemia--current status and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

The myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Activating alleles of JAK3 in acute megakaryoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Stat5 is essential for early B cell development but not for B cell maturation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Denaturing high-performance liquid chromatography for the detection of mutations and polymorphisms in UBE3A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Molecular evidence for true isochromosome 21q

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Prediction of chromosomal aneuploidy from gene expression data.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Trisomy of chromosome 21 in leukemogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961341-0

7 January 2021

10.1016/S0140-6736(08)61341-0

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

18805579

1 reference

21 December 2017